These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3758429)
1. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. I. PSL pharmacokinetics during daily PSL treatment]. Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):697-712. PubMed ID: 3758429 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. II. PSL pharmacokinetics during intermittent treatment with PSL administration 4 consecutive days a week]. Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K Nihon Naibunpi Gakkai Zasshi; 1987 May; 63(5):675-94. PubMed ID: 3622862 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of plasma total and free prednisolone during an alternate-day regimen. Fuwa Y; Yasuda K; Adachi K; Goshima E; Yamakita N; Miura K Nihon Naibunpi Gakkai Zasshi; 1991 Jan; 67(1):8-22. PubMed ID: 2013347 [TBL] [Abstract][Full Text] [Related]
4. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan. Kubota S; Nishihara E; Kudo T; Ito M; Amino N; Miyauchi A Thyroid; 2013 Mar; 23(3):269-72. PubMed ID: 23227861 [TBL] [Abstract][Full Text] [Related]
5. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis. Arao T; Okada Y; Torimoto K; Kurozumi A; Narisawa M; Yamamoto S; Tanaka Y J UOEH; 2015 Jun; 37(2):103-10. PubMed ID: 26073499 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration. Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661 [TBL] [Abstract][Full Text] [Related]
7. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Chen MF; Shimada F; Kato H; Yano S; Kanaoka M Endocrinol Jpn; 1991 Apr; 38(2):167-74. PubMed ID: 1752235 [TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus. Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K Intern Med; 2019 May; 58(9):1257-1262. PubMed ID: 30626831 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration. Bergrem H; Grøttum P; Rugstad HE Eur J Clin Pharmacol; 1983; 24(3):415-9. PubMed ID: 6861855 [TBL] [Abstract][Full Text] [Related]
10. [Combined effect of cyclosporin and prednisolone for minimal change nephrotic syndrome: comparison with prednisolone therapy]. Hayashi M; Kimura N; Fukatsu A Nihon Jinzo Gakkai Shi; 2008; 50(5):581-7. PubMed ID: 18767486 [TBL] [Abstract][Full Text] [Related]
11. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome. Frey FJ; Frey BM Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone. Mizukoshi T; Noguchi S; Murakami T; Futata T; Yamashita H Intern Med; 2001 Apr; 40(4):292-5. PubMed ID: 11334386 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309 [TBL] [Abstract][Full Text] [Related]
19. Oral corticosteroid therapy and present disease status in myasthenia gravis. Imai T; Suzuki S; Tsuda E; Nagane Y; Murai H; Masuda M; Konno S; Suzuki Y; Nakane S; Fujihara K; Suzuki N; Utsugisawa K Muscle Nerve; 2015 May; 51(5):692-6. PubMed ID: 25155615 [TBL] [Abstract][Full Text] [Related]
20. [A comparison of a 3 day course with a 2 week course of oral prednisolone in patients with chronic asthma]. Hasegawa T; Ishihara K; Fujii H; Nishimura T; Umeda B Arerugi; 1998 May; 47(5):543-9. PubMed ID: 9656577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]